Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Fredun Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:539730NSE Symbol: Not ListedP/E(TTM):28.57
ISIN Demat:INE194R01017Div & Yield %:0.05EPS(TTM):49.65
Book Value(Rs):299.4743419Market Cap ( Cr.):669.86Face Value(Rs):10
    Change Company 
Date Headline
03-Oct-25 Fredun Pharmaceuticals to hold EGM
01-Oct-25 Fredun Pharmaceuticals Ltd - Shareholder Meeting / Postal Ballot-Scrutinizers Report
01-Oct-25 Fredun Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
27-Sep-25 Fredun Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
23-Sep-25 Fredun Pharmaceuticals announces board meeting date
22-Sep-25 Fredun Pharmaceuticals Ltd - Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The Securities And Exc..
16-Sep-25 Fredun Pharmaceuticals to hold AGM
31-Jul-25 Fredun Pharmaceuticals standalone net profit rises 63.92% in the June 2025 quarter
15-Jul-25 Fredun Pharmaceuticals to convene board meeting
20-Jun-25 Fredun Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Demise
<< < 1 2 3 > >>